ARS Pharmaceuticals (SPRY) Insider Trading & Ownership $14.01 -0.10 (-0.71%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ARS Pharmaceuticals (NASDAQ:SPRY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage40.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$8.92 MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$33.62 M Get SPRY Insider Trade Alerts Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRY Insider Buying and Selling by Quarter Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. ARS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024James E FlynnMajor ShareholderSell528,456$18.04$9,533,346.24 10/16/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 10/15/2024Sarina TanimotoInsiderSell100,000$14.88$1,488,000.00 10/8/2024Richard E LowenthalCEOSell100,000$13.83$1,383,000.00 9/18/2024Eric KarasInsiderSell10,000$14.00$140,000.00 9/17/2024Richard E LowenthalCEOSell100,000$12.93$1,293,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/26/2024Peter A ThompsonDirectorSell83,695$13.00$1,088,035.00 8/23/2024Peter A ThompsonDirectorSell69,500$13.03$905,585.00 8/21/2024Peter A ThompsonDirectorSell407,700$13.56$5,528,412.00 8/20/2024Brian DorseyCOOSell50,000$15.00$750,000.00 8/20/2024Kathleen D ScottCFOSell12,500$16.00$200,000.00 8/20/2024Richard E LowenthalCEOSell100,000$15.03$1,503,000.00 8/19/2024Eric KarasInsiderSell10,000$14.00$140,000.00 7/16/2024Richard E LowenthalCEOSell100,000$11.40$1,140,000.00 7/9/2024Sarina TanimotoInsiderSell100,000$9.62$962,000.00 6/12/2024Sarina TanimotoInsiderSell95,862$9.15$877,137.30 6/11/2024Richard E LowenthalCEOSell4,138$9.00$37,242.00 5/16/2024Sarina TanimotoInsiderSell89,096$9.06$807,209.76 5/15/2024Richard E LowenthalCEOSell5,147$9.05$46,580.35 5/14/2024Sarina TanimotoInsiderSell5,757$9.01$51,870.57 5/7/2024Sarina TanimotoInsiderSell100,000$9.34$934,000.00 4/16/2024Sarina TanimotoInsiderSell100,000$9.28$928,000.00 4/9/2024Richard E LowenthalCEOSell100,000$9.28$928,000.00 3/27/2024Ra Capital Management, L.P.DirectorBuy505,954$9.79$4,953,289.66 3/25/2024Ra Capital Management, L.P.DirectorBuy437,600$9.06$3,964,656.00 3/25/2024Richard E LowenthalCEOSell95,267$9.12$868,835.04 3/22/2024Sarina TanimotoInsiderSell2,343$9.02$21,133.86 3/21/2024Richard E LowenthalCEOSell472$9.00$4,248.00 3/19/2024Richard E LowenthalCEOSell1,918$9.03$17,319.54 3/15/2024Richard E LowenthalCEOSell96,756$9.14$884,349.84 3/14/2024Sarina TanimotoInsiderSell444$9.00$3,996.00 3/13/2024Richard E LowenthalCEOSell2,800$9.00$25,200.00 2/29/2024Richard E LowenthalCEOSell3,782$9.02$34,113.64 2/28/2024Sarina TanimotoInsiderSell98,778$9.02$890,977.56 2/26/2024Sarina TanimotoInsiderSell700$9.01$6,307.00 (Data available from 1/1/2013 forward) SPRY Insider Trading Activity - Frequently Asked Questions Who is on ARS Pharmaceuticals's Insider Roster? The list of insiders at ARS Pharmaceuticals includes Alexander A Fitzpatrick, Brian Dorsey, Eric Karas, James E Flynn, Kathleen D Scott, Laura Shawver, Peter A Thompson, Ra Capital Management, L.P., Richard E Lowenthal, and Sarina Tanimoto. Learn more on insiders at SPRY. What percentage of ARS Pharmaceuticals stock is owned by insiders? 40.10% of ARS Pharmaceuticals stock is owned by insiders. Learn more on SPRY's insider holdings. Which ARS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SPRY shares in the last 24 months: Alexander A Fitzpatrick ($144,800.00), Kathleen D Scott ($51,480.00), and Ra Capital Management, L.P. ($40,348,945.66). How much insider buying is happening at ARS Pharmaceuticals? Insiders have purchased a total of 7,441,804 SPRY shares in the last 24 months for a total of $40,545,225.66 bought. Which ARS Pharmaceuticals insiders have been selling company stock? The following insiders have sold SPRY shares in the last 24 months: Brian Dorsey ($750,000.00), Eric Karas ($280,000.00), James E Flynn ($9,533,346.24), Kathleen D Scott ($400,000.00), Laura Shawver ($2,276,913.11), Peter A Thompson ($7,522,032.00), Richard E Lowenthal ($8,164,888.41), and Sarina Tanimoto ($6,970,632.05). How much insider selling is happening at ARS Pharmaceuticals? Insiders have sold a total of 2,918,778 ARS Pharmaceuticals shares in the last 24 months for a total of $35,897,811.81 sold. ARS Pharmaceuticals Key ExecutivesMr. Richard Lowenthal M.B.A. (Age 58)M.S., MSMSEL, Founder, President, CEO & Director Compensation: $2.75MDr. Sarina Tanimoto M.B.A. (Age 55)M.D., Co-Founder & Chief Medical Officer Compensation: $2.47MMr. Alexander A. Fitzpatrick Esq. (Age 57)Chief Legal Officer & Secretary Compensation: $677.14kDr. Robert Bell Ph.D.Co-Founder & Chief Science OfficerMs. Kathleen D. Scott CPAChief Financial Officer2 recent tradesMr. Brian T. Dorsey M.S. (Age 55)Chief Operations Officer Mr. Daniel RelovskySenior Vice President of MarketingMr. Harris Kaplan M.B.A. (Age 72)Executive Vice President of Commercial Strategy Mr. Eric Karas (Age 51)Chief Commercial Officer Compensation: $618.61k2 recent tradesMr. Justin Chakma (Age 34)Chief Business Officer & Secretary More Insider Trading Tools from MarketBeat Related Companies KRYS Insider Trading RNA Insider Trading BHVN Insider Trading RARE Insider Trading BBIO Insider Trading ACLX Insider Trading CRNX Insider Trading IMVT Insider Trading ADMA Insider Trading OGN Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:SPRY) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
